314 related articles for article (PubMed ID: 15196869)
1. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
Hall WB; Detterbeck FC; Livasy CA; Fowler WC
Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
[TBL] [Abstract][Full Text] [Related]
2. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
[TBL] [Abstract][Full Text] [Related]
3. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
[TBL] [Abstract][Full Text] [Related]
4. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
DeMars LR; Van Le L; Huang I; Fowler WC
Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero.
Boyd J; Takahashi H; Waggoner SE; Jones LA; Hajek RA; Wharton JT; Liu FS; Fujino T; Barrett JC; McLachlan JA
Cancer; 1996 Feb; 77(3):507-13. PubMed ID: 8630958
[TBL] [Abstract][Full Text] [Related]
6. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
7. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
Herbst AL; Scully RE; Robboy SJ
J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
9. The current status of the DES-exposed population.
Herbst AL
Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
[TBL] [Abstract][Full Text] [Related]
10. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
Blythe JG; Michael H; Hodel KA
J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
[TBL] [Abstract][Full Text] [Related]
11. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
12. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
13. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
Herbst AL
Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
[No Abstract] [Full Text] [Related]
14. Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix.
Hanselaar AG; Boss EA; Massuger LF; Bernheim JL
Gynecol Oncol; 1999 Dec; 75(3):338-44. PubMed ID: 10600286
[TBL] [Abstract][Full Text] [Related]
15. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
16. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma.
Palmer JR; Anderson D; Helmrich SP; Herbst AL
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):814-20. PubMed ID: 10831973
[TBL] [Abstract][Full Text] [Related]
18. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
[TBL] [Abstract][Full Text] [Related]
19. DES-related clear cell adenocarcinoma of the vagina in pregnancy.
Jones WB; Woodruff JM; Erlandson RA; Lewis JL
Obstet Gynecol; 1981 Jun; 57(6 Suppl):76S-80S. PubMed ID: 7243130
[TBL] [Abstract][Full Text] [Related]
20. Delayed onset of clear cell adenocarcinoma of the vagina in DES-exposed progeny.
Veridiano NP; Tancer ML; Delke I; Gal D; Giannattasio C
Obstet Gynecol; 1981 Mar; 57(3):395-8. PubMed ID: 7465156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
